Loading...
Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
BACKGROUND: This is an updated version of the original Cochrane review published in 2015, Issue 10. Severe myoclonic epilepsy in infants (SMEI), also known as Dravet syndrome, is a rare, refractory form of epilepsy, for which stiripentol (STP) has been recently licensed as add‐on therapy. OBJECTIVES...
Saved in:
| Published in: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley & Sons, Ltd
2017
|
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481545/ https://ncbi.nlm.nih.gov/pubmed/28521067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010483.pub4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|